Drug · DIN 02243118
APTHERA
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since August 3, 2017.
- Drug Identification Number (DIN)
- 02243118
- Company (DIN owner)
- Pharmascience Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Paste
- Route
- Oral
- Therapeutic class (ATC)
- Amlexanox A01AD07
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AMLEXANOX | 5 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 4, 2002: NOC 227New Drug Submission (NDS) · Manufacturer name change
- December 11, 2000: NOC 934New Drug Submission (NDS)